Immunogenicity and safety in children 1 - 9 years of a vaccine against meningococcal serogroup C strain 2135 produced with tetanus toxoid conjugate
Latest Information Update: 27 Apr 2011
At a glance
- Drugs Meningococcal vaccine group C conjugate (Primary)
- Indications Meningococcal group C infections
- Focus Pharmacodynamics
Most Recent Events
- 27 Apr 2011 New trial record